Predictive Value of Lymphocyte Based Indices to Determine Major Adverse Cardiovascular Events in Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Predictive Value of Lymphocyte Based Indices to Determine Major Adverse Cardiovascular Events in Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Published:2024-03-02 Issue: Volume: Page:
ISSN:0970-1915
Container-title:Indian Journal of Clinical Biochemistry
language:en
Short-container-title:Ind J Clin Biochem

Author:

Mohanty Vivek,Deora Surender^ORCID,Kaushik Atul,Choudhary Rahul,Yadav Dharamveer,Singh Kuldeep

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12291-024-01188-x.pdf

Reference29 articles.

1. Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol. 2020;76(25):2980–1. https://doi.org/10.1016/j.jacc.2020.11.021.

2. Kong G, Chin YH, Chong B, Goh RSJ, Lim OZH, Ng CH, et al. Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients. Int J Cardiol. 2023;371:432–40. https://doi.org/10.1016/j.ijcard.2022.09.062.

3. Przybysz-Zdunek B, Ploch M, Pluta W, Dada M, Opolski G. All-cause readmission and repeat revascularization after percutaneous coronary intervention. Cardiol J. 2012;19(2):174–9. https://doi.org/10.5603/cj.2012.0030.

4. Fox KA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, Buysschaert I, Lambrechts D, Van de Werf F. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J. 2010;31(22):2755–64. https://doi.org/10.1093/eurheartj/ehq326.

5. Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–27. https://doi.org/10.1161/CIRCRESAHA.118.313591.